Engineered by BioPhotonix
Revolux photobiomodulation (PBM) actively stimulates and repairs compromised retinal cells, helping to preserve central vision and maintain independence in patients with early and intermediate dry macular degeneration.
In just 5 minutes per session, our technology targets the root cause of decline to repair retinal health and protect sight. Whether accessed in a local optometry clinic or a supervised home visit, patients can finally gain the upper hand against dry macular degeneration—experiencing clearer vision, protected independence, and a renewed quality of life.
For your clinic, it seamlessly integrates hospital-grade care into routine workflows—turning unmet patient needs into a scalable, high-value revenue stream.
Designed for Clinical Impact
We replaced the fixed console with a precision binocular system that fits your workflow, not the other way around.
Treat Early
Intervene when it matters most—before irreversible vision loss occurs.
Any Room, Any Time
Portable binocular design fits standard consulting rooms—no dedicated infrastructure required.
Precision Dosing
Unlike desktop systems, our technology guarantees exact source-to-eye geometry for every patient, every time.
Intelligent Delivery
Revolux combines biological optimisation with digital intelligence.
Retinal Restoration
Our unique treatment protocol targets the key cause of Dry AMD - Mitochondrial Dysfunction. Revolux combines wavelengths with the strongest clinical effect, boosting and restoring mitochondrial functional.
Bio-Optimised Therapy
Standard devices just emit light. Revolux uses proprietary "Soft-Start" and stability algorithms to ensure the retina is metabolically prepared to receive treatment, maximising cellular response.
Intelligent Insight
Integrated software converts complex treatment data into clinician-ready reports and patient-friendly summaries, reducing administrative burden and boosting compliance.
Technology
You Can Trust
Revolux is built on a foundation of rigorous quality and regulatory compliance,
ensuring it meets the demands of modern healthcare environments.
Medical Device Validation
Developed under a certified ISO 13485 Quality Management System, Revolux is engineered to meet Class IIa medical device standards (UKCA/MDR), ensuring validated optical, electrical, and biological safety.
Active Safety Interlocks
The system utilises intelligent inhibition logic to guarantee safety.
Dosage and irradiance is strictly controlled and monitored, ensuring consistency and safety for every treatment.
Auditable Care
Unlike unsupervised consumer devices, Revolux is designed for accountability. Every treatment session is clinician-initiated and digitally logged, ensuring patients remain within a managed, traceable care pathway.